Vapogenix
Houston, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
MC
Motter ClariceExecutive
CJ
Christopher JorgesonNamed on SEC filing
DS
Danguole SpakeviciusNamed on SEC filing
CM
Clay M HeightenNamed on SEC filing
Board
GD
George DavittBoard director
CJ
Christopher JorgensenBoard director
BG
Bruce GivenBoard director
ML
Marc LoevBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$11.9M disclosed across 3 rounds · 2014–2017
▶$1.6MraisedJan 2018 · 7 investors · PharmaceuticalsRule 506(b)
▶$1.6MraisedJan 2018 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- George DavittDirector
- Bruce GivenDirector
- Christopher JorgensenDirector
- Marc LoevDirector
- Motter ClariceExecutive Officer
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- Minimum investment
- $20K
- Proceeds to insiders
- $190K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.2MraisedDec 2016 · 37 investors · PharmaceuticalsRule 506(b)
▶$8.2MraisedDec 2016 · 37 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Danguole AltmanExecutive Officer, Director
- Christopher JorgensenDirector
- George DavittDirector
- Marc LoevDirector
- Offering amount
- $8.6M
- Amount sold
- $8.2M
- Minimum investment
- $20K
- Finders' fees
- $174.3K
- Proceeds to insiders
- $360K
- Placement agents
- Sword Securities, LLC
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedDec 2014 · 18 investors · Pharmaceuticals
▶$2.1MraisedDec 2014 · 18 investors · Pharmaceuticals
Officers, directors & promoters on the filing
- Christopher JorgesonDirector
- Danguole SpakeviciusExecutive Officer, Director
- Clay M HeightenDirector
- George DavittDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- Minimum investment
- $25K
- Proceeds to insiders
- $200K
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 05
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $907.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $223.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Vapogenix's investors?
- Vapogenix's investors include IrishAngels.
- How much funding has Vapogenix raised?
- Vapogenix has disclosed $11.9M raised across 3 rounds.
- Where is Vapogenix headquartered?
- Vapogenix is headquartered in Houston, US.